# Cancer Incidence and Trends in Persistent Poverty Areas of California by Race/Ethnicity and Sex

**Authors:** Ani S. Movsisyan Vernon, Frances B. Maguire, Ayman T. Ullah, Brenda M. Hofer, Arti Parikh‐Patel, Ted Wun, Shehnaz K. Hussain, Theresa H. M. Keegan

PMC · DOI: 10.1002/cam4.71088 · Cancer Medicine · 2025-07-30

## TL;DR

This study examines how living in persistent poverty areas in California affects cancer rates and trends, finding higher cancer incidence among residents in these areas.

## Contribution

The study identifies cancer incidence disparities by race/ethnicity and sex in persistent poverty areas of California.

## Key findings

- Male patients in PPAs had higher incidence rate ratios for colorectal, liver, lung, and stomach cancers.
- Female patients in PPAs had higher incidence rate ratios for cervical, kidney, liver, and stomach cancers.
- Cancer incidence trends varied by race/ethnicity and poverty status, with some cancers increasing only in PPAs.

## Abstract

Although previous studies have observed the relationship between living in persistent poverty areas (PPAs) and adverse cancer outcomes, the relationship between residing in PPAs and disparities in cancer incidence rates and temporal trends by race/ethnicity and sex in California is unknown.

We used California Cancer Registry data to identify patients diagnosed with 16 common cancers between 2006 and 2020. We calculated age‐adjusted incidence rates (IRs), incidence rate ratios (IRRs), and average annual percent changes (AAPCs) to compare incidence and temporal trends in PPAs and non‐PPAs in California by race/ethnicity and sex. PPA was defined as areas with a poverty rate of 20% or more for approximately 30 continuous years.

Male patients in PPAs had significantly higher IRRs of colorectal, liver, lung, and stomach cancers, and female patients had higher cervical, kidney, liver, and stomach cancers. Across all racial/ethnic groups, cervical and liver cancer IRRs were significantly higher, and IRRs for female breast cancer were lower in PPAs. The incidence of several cancers significantly decreased over time only in non‐PPAs. Colorectal cancer and non‐Hodgkin lymphoma among Hispanic residents significantly increased in PPAs (AAPC = 0.4, 1.2) and colorectal cancer decreased only in non‐PPAs (AAPC = −1.4). Thyroid cancer among non‐Hispanic Black residents increased only in PPAs (AAPC = 4.7).

Our findings highlight race/ethnicity and sex disparities in cancer incidence and temporal trends for PPA residents. Further research is needed to understand the specific etiological factors underlying these disparities, and to support the development of public health policies and initiatives to decrease the cancer burden in California.

## Linked entities

- **Diseases:** colorectal cancer (MONDO:0005575), liver cancer (MONDO:0002691), lung cancer (MONDO:0005138), stomach cancer (MONDO:0001056), cervical cancer (MONDO:0002974), kidney cancer (MONDO:0002367), non-Hodgkin lymphoma (MONDO:0018908), thyroid cancer (MONDO:0002108), female breast cancer (MONDO:0004379)

## Full-text entities

- **Diseases:** PPA (MESH:D000088562), kidney cancer (MESH:D007680), leukemia (MESH:D007938), hypertension (MESH:D006973), carcinogens (MESH:D011230), MASLD (MESH:D008107), cervical, kidney, liver, melanoma, pancreatic, stomach, and thyroid cancers (MESH:C563985), Thyroid cancer (MESH:D013964), Non-Hodgkin lymphoma (MESH:D008228), AAPCs (MESH:D009402), cervical cancer (MESH:D002583), lung (MESH:D008171), COVID-19 (MESH:D000086382), Melanoma (MESH:D008545), cervical (MESH:D002575), , thyroid (MESH:D013966), oropharyngeal (MESH:D009959), Liver cancer (MESH:D006528), pancreatic cancer (MESH:D010190), obesity (MESH:D009765), tobacco (MESH:D014029), H. pylori (MESH:D016481), hepatitis C (MESH:D019698), , and uterine (MESH:D014591), Cancer (MESH:D009369), bladder cancer (MESH:D001749), liver (MESH:D017093), infection (MESH:D007239), breast (MESH:D061325), Colorectal cancer (MESH:D015179), prostate cancer (MESH:D011471), type 2 diabetes (MESH:D003924), cervical and stomach cancer (MESH:D013274), and pancreatic (MESH:D010195), breast, prostate, and melanoma (MESH:D011472), Breast cancer (MESH:D001943), alcoholic and metabolic dysfunction-associated steatotic liver disease (MESH:D008108), kidney (MESH:D007674), and stomach (MESH:D013272), PPA (MESH:D057178), Hepatitis B (MESH:D006509), diabetes (MESH:D003920), bladder (MESH:D001745), lung cancer (MESH:D008175)
- **Chemicals:** alcohol (MESH:D000438), PPAs (-)
- **Species:** Nicotiana tabacum (American tobacco, species) [taxon 4097], Human papillomavirus (species) [taxon 10566], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12308746/full.md

## References

73 references — full list in the complete paper: https://tomesphere.com/paper/PMC12308746/full.md

---
Source: https://tomesphere.com/paper/PMC12308746